Serological cross-reaction between high molecular weight proteins synthesized in blood schizonts of Plasmodium yoelii, Plasmodium chabaudi and Plasmodium falciparum
- PMID: 6201740
- DOI: 10.1016/0166-6851(83)90096-8
Serological cross-reaction between high molecular weight proteins synthesized in blood schizonts of Plasmodium yoelii, Plasmodium chabaudi and Plasmodium falciparum
Abstract
A 230 000 molecular weight (MW) Plasmodium yoelii protein, a 250 000 MW P. chabaudi protein and a 195 000 MW P. falciparum protein, identified using monoclonal antibodies, have similar characteristics, and have been implicated as protective antigens. In this study the serological relationship between these proteins was investigated by Western transfer analysis. The monoclonal antibodies specific for each of the high molecular weight proteins did not cross-react with antigens of the other two parasites, but a polyvalent mouse serum raised against the purified 230 000 MW P. yoelii protein cross-reacted with the high molecular weight proteins of P. chabaudi and P. falciparum and also with the fragments derived from these proteins. This result indicates that these proteins belong to the same class of malaria parasite antigen.
Similar articles
-
Serum antibody immunoglobulin G of mice convalescent from Plasmodium yoelii infection inhibits growth of Plasmodium falciparum in vitro: blood stage antigens of P. falciparum involved in interspecies cross-reactive inhibition of parasite growth.Infect Immun. 1994 Jun;62(6):2354-61. doi: 10.1128/iai.62.6.2354-2361.1994. Infect Immun. 1994. PMID: 8188358 Free PMC article.
-
Cross-reacting antigens to Pc96, a protective antigen of Plasmodium chabaudi, in P. falciparum, P. vivax, and P. cynomolgi.Am J Trop Med Hyg. 1989 Jun;40(6):579-84. doi: 10.4269/ajtmh.1989.40.579. Am J Trop Med Hyg. 1989. PMID: 2472747
-
Characterization of a high molecular weight protective antigen of Plasmodium yoelii.Parasitology. 1984 Apr;88 ( Pt 2):211-9. Parasitology. 1984. PMID: 6718053
-
Protective antigens of rodent and human bloodstage malaria.Philos Trans R Soc Lond B Biol Sci. 1984 Nov 13;307(1131):171-7. doi: 10.1098/rstb.1984.0117. Philos Trans R Soc Lond B Biol Sci. 1984. PMID: 6151681 Review.
-
Human antibodies against Plasmodium falciparum liver-stage antigen 3 cross-react with Plasmodium yoelii preerythrocytic-stage epitopes and inhibit sporozoite invasion in vitro and in vivo.Infect Immun. 2001 Jun;69(6):3845-52. doi: 10.1128/IAI.69.6.3845-3952.2001. Infect Immun. 2001. PMID: 11349050 Free PMC article.
Cited by
-
Studies of murine malaria antigens using monoclonal antibodies. Production, selection, and characterization of antibodies.Z Parasitenkd. 1986;72(5):599-607. doi: 10.1007/BF00925481. Z Parasitenkd. 1986. PMID: 3535284
-
Analysis of antibodies directed against merozoite surface protein 1 of the human malaria parasite Plasmodium falciparum.Infect Immun. 2006 Feb;74(2):1313-22. doi: 10.1128/IAI.74.2.1313-1322.2006. Infect Immun. 2006. PMID: 16428781 Free PMC article.
-
Vaccination with a purified blood-stage malaria antigen in mice: correlation of protection with T cell mediated immunity.Clin Exp Immunol. 1985 Oct;62(1):19-23. Clin Exp Immunol. 1985. PMID: 2933196 Free PMC article.
-
Polymorphism of a high molecular weight schizont antigen of the human malaria parasite Plasmodium falciparum.J Exp Med. 1985 Jan 1;161(1):160-80. doi: 10.1084/jem.161.1.160. J Exp Med. 1985. PMID: 2578540 Free PMC article.
-
The 3' portion of the gene for a Plasmodium yoelii merozoite surface antigen encodes the epitope recognized by a protective monoclonal antibody.Proc Natl Acad Sci U S A. 1988 Jan;85(2):602-6. doi: 10.1073/pnas.85.2.602. Proc Natl Acad Sci U S A. 1988. PMID: 2448778 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources